Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06387316 · ClinicalTrials.gov registry record · NA
Cephalic Phase Responses to Nutritive and Non-Nutritive Sweeteners
A NA study of PreDiabetes, sponsored by Purdue University.
- Active
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT06387316: Active NA study of PreDiabetes, sponsored by Purdue University.
NCT06387316 is a NA study of PreDiabetes that is active but no longer recruiting, run by Purdue University. The registered enrollment target is 30 participants, below the 701-participant average among 149 other PreDiabetes trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06387316, a NA study of PreDiabetes, is active but no longer recruiting, sponsored by Purdue University.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will focus on changes in blood sugar in response to tasting different types of sweeteners using continuous glucose monitoring (CGM) technology.
Conditions Studied
Interventions
- OTHER No Oral Stimulation
- OTHER Oral water stimulation
- OTHER Oral Salt Stimulation
- OTHER Oral Sucralose Stimulation
- OTHER Oral Sucrose stimulation
Study Locations (1)
Indiana
- Purdue University - West Lafayette
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2024-03-26 |
| Est. Completion | 2025-03-30 |
| Phase | NA |
What the registry record for NCT06387316 still lists
NCT06387316 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 701-participant average among 149 other PreDiabetes trials with a reported enrollment target (96% lower).
The record links to 1 condition, with PreDiabetes appearing as the primary indexed condition, and to 5 interventions - of which No Oral Stimulation is the first listed.
NCT06387316 reports a single indexed study location in Indiana.
Frequently Asked Questions
What is clinical trial NCT06387316 about?
NCT06387316 is a clinical study titled "Cephalic Phase Responses to Nutritive and Non-Nutritive Sweeteners". This study will focus on changes in blood sugar in response to tasting different types of sweeteners using continuous glucose monitoring (CGM) technology.
What is the current status of trial NCT06387316?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2024-03-26. Estimated completion is 2025-03-30.
What conditions does trial NCT06387316 study?
This clinical trial studies the following conditions: PreDiabetes.
What interventions are being tested in trial NCT06387316?
The interventions under investigation include: No Oral Stimulation (OTHER), Oral water stimulation (OTHER), Oral Salt Stimulation (OTHER), Oral Sucralose Stimulation (OTHER), Oral Sucrose stimulation (OTHER).
Who is sponsoring clinical trial NCT06387316?
This trial is sponsored by Purdue University, which has 141 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06387316 being conducted?
This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for PreDiabetes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06387316's enrollment target sits among peer trials
30 118th of 149 higher than 23 of 149 other PreDiabetes trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other PreDiabetes trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Longitudinal Multi-Omic Profiles to Reveal Mechanisms of Obesity-Mediated Insulin Resistance
RECRUITING · NA
-
Black Impact: The Mechanisms Underlying Psychosocial Stress Reduction in a Cardiovascular Health Intervention
RECRUITING · NA
-
Diabetes Clinical Decision Support
RECRUITING · NA
-
Food as Medicine for HIV and Diabetes
RECRUITING · NA
-
Cleaner Air for Lower Cardiometabolic Risk
RECRUITING · NA
-
Strategies for Implementing a Postpartum Lifestyle Intervention in WIC Clinics
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI